| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harmony Biosciences Holdings, Inc. (HRMY) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. HRMY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 24.5K | $759.9K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - | |
| Dir | 14.5K | $450.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Kapadia Sandip71 | Chief Financial Officer | Sale+OE | 25,000 | $40.18 | $1,004,597.50 | -100% | -29.6% | -9.3% | |
| Jan 21, 2025 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 30,598 | $37.51 | $1,147,715.34 | -100% | -29.6% | -9.3% | |
| Jan 15, 2025 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 10,507 | $37.01 | $388,840.95 | -100% | -22.2% | -1.4% | |
| Jan 13, 2025 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 7,180 | $37.04 | $265,946.48 | -100% | -19.0% | -1.9% | |
| Nov 5, 2024 | Marshman Fund Trust II | 10% Owner | Sell | 4,600,000 | $30.30 | $139,391,500.00 | -26.6% | +15.8% | -6.2% | |
| Nov 5, 2024 | Valor IV Pharma Holdings, LLC | 10% Owner | Sell | 4,600,000 | $30.30 | $139,391,500.00 | -25.0% | +15.8% | -6.2% | |
| Oct 29, 2024 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 21,496 | $40.47 | $870,018.36 | -100% | -7.8% | -29.3% | |
| Oct 3, 2024 | Dierks Jeffrey62 | Chief Commercial Officer | Sell | 36,357 | $35.06 | $1,274,546.50 | -98.1% | +0.2% | -21.5% | |
| Oct 1, 2024 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 400 | $40.19 | $16,076.92 | -100% | -13.2% | -31.4% | |
| Sep 30, 2024 | Dierks Jeffrey62 | Chief Commercial Officer | Sale+OE | 35,846 | $40.03 | $1,434,951.23 | -100% | -14.8% | -31.1% |